Cytokine Engineering: IL-2, IL-15, and Beyond Check out our extensive video library (see channel for our latest videos) Abstract This paper looks into cytokine engineering, with particular focus on interleukin-2 (IL-2) and interleukin-15 (IL-15). These proteins play essential roles in immune system regulation and
Tag: immunotherapy
Fecal Microbiota Transplantation: From Gut Health to Cancer Treatment Success
Fecal Microbiota Transplantation: From Gut Health to Cancer Treatment Success Introduction Fecal microbiota transplantation (FMT) has emerged as a novel and highly promising strategy in the field of cancer immunotherapy. Recent clinical studies have reported objective response rates of up to 65 percent among
Monotherapy Or Chemotherapy Adjunct: Pembrolizumab In Advanced NSCLC
Monotherapy Or Chemotherapy Adjunct: Pembrolizumab In Advanced NSCLC Objectives To assess the effectiveness and safety of pembrolizumab monotherapy and in combination with chemotherapy in patients with advanced non–small-cell lung cancer (NSCLC). Introduction Historically, patients with advanced NSCLC have a poor prognosis despite the use of platinum-based chemotherapy drugs. The 5-year relative survival rate of
Renal Cell Carcinoma- Prognosis via Albumin Levels
Renal Cell Carcinoma- Prognosis via Albumin Levels Metastatic renal cell carcinoma (mRCC) - An Introduction Renal cell carcinoma (RCC) constitutes approximately 90% of all urologic malignancies. Approximately 30% of patients with RCC present with metastatic disease, and amongst those with localized disease, a substantial proportion will recur. Before 2005, immunotherapy with interleukin-2
